Position in AMGN
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$2,480,522
+$28,480 QoQ
Shares Held
6,850
-1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,153
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Procyon Advisors, LLC holds $38,982,476 across 11 Drug Manufacturers - General names. AMGN ranks #5 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
32,392 | $8,151,122 | |
| 2 | JNJ |
Johnson & Johnson
|
30,495 | $7,744,815 | |
| 3 | LLY |
ELI LILLY & Co
|
6,408 | $7,685,948 | |
| 4 | MRK |
Merck & Co., Inc.
|
50,916 | $6,542,706 | |
| 5 | AMGN |
Amgen Inc
This page
|
6,850 | $2,480,522 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
17,103 | $2,160,793 | |
| 7 | PFE |
Pfizer Inc
|
55,347 | $1,332,755 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,718 | $963,291 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,480,522 | 6,850 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $2,452,042 | 6,969 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,310,481 | 7,059 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $2,168,424 | 7,684 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $2,392,271 | 8,568 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $3,323,303 | 10,667 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $2,540,718 | 9,748 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $3,016,852 | 9,363 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $3,191,676 | 10,215 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $3,196,609 | 11,243 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $3,213,151 | 11,156 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $3,175,399 | 11,815 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $2,337,204 | 10,527 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $1,998,789 | 8,268 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $1,862,117 | 7,090 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $1,479,074 | 6,562 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,442,525 | 5,929 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $1,416,823 | 5,859 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $1,307,075 | 5,810 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,040,283 | 4,892 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $335,156 | 1,375 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $310,763 | 1,249 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $262,108 | 1,140 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $285,675 | 1,124 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $234,208 | 993 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $113,528 | 560 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||